Anna-Elisabeth Keuder (Cellbricks)
As a bioprinting scientist Anna, 29, evolves Cellbricks’ proprietary 3D bioprinting technology to create living biological tissue. Human biologist by training, her interest in alternative testing systems and the vision to improve those grew during her studies in applied medical and basic pharmacological research (at KIST Europe and Yale University respectively). As part of the Cellbricks team since its start in 2015, Anna’s vision is to make drug testing more efficient and safe by creating complex biological testing systems. Her current focus is the development of a printed placenta model ‘in a petri dish’, eventually enabeling risk assessment of compounds for pregnant women and unborns.